Israeli AI Startup Converge Bio Raises $25M to Transform Drug Discovery
Israeli AI startup Converge Bio secures $25 million Series A funding, bringing total to $30M for its AI drug discovery platform.
















Real-time breaking news coverage from Israel and the Middle East. Stay informed with the latest developments as they happen.
Israeli AI startup Converge Bio secures $25 million Series A funding, bringing total to $30M for its AI drug discovery platform.
Israel's Ministry of Health offers a free AI course for bio-researchers, focusing on practical application of AI tools in biomedical research and the ERA4Health.
Israeli scientists developed a new biosensor at Hebrew University that glows to detect wine spoilage in real-time, offering winemakers crucial early warnings to.
Israeli AI Biotech Immunai partners with Bristol Myers Squibb, utilizing its AMICA-OS platform to accelerate drug development. This collaboration promises to.
Israeli biotech MeMed receives $2 million grant for AI-driven diagnostics biobank to accelerate development of high-risk patient tools.
An Israeli biotech breakthrough from the Weizmann Institute of Science allows doctors to track immunity to new viruses in minutes, crucial for future pandemic.
New Israeli research offers a roadmap for more effective antibiotic treatments by revealing two distinct bacterial growth-arrest states. This discovery will.
Prime Minister Benjamin Netanyahu is currently meeting with US Secretary of State Marco Rubio in Florida today, discussing key issues.
Israeli scientists at Hebrew University discovered a viral switch in bacteriophages, offering a new front to fight antibiotic-resistant bacteria, a global.
Israeli biotech Amorphical announces breakthrough Crohn’s therapy, achieving sustained remission with nano-amorphous Calcium Carbonate in Phase 2 trial at.